Search results for "process development"
Article
Techniques for Improving Process Development for Exosome-Derived Therapeutics
Here, the Process Development Forum speaks with Aaron Noyes, Head of Downstream Processing, at Codiak BioSciences about exosomes, their potential clinical applications, and process innovations that wo…
Article
Design of Experiments for Analytical Method Development and Validation
Design of experiments (DOE) is a well-proven characterization approach within product and process development and a key aspect of quality by design. Recently, more attention has been placed on applyin…
Article
Can Vaccine Development Be Safely Accelerated?
Can Vaccine Development Be Safely Accelerated?
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
By Cynthia A. Ch…
Article
Top Tips for Successful Development of Antibody Chromatography Processes
So it's the same impurities, but it's difficult not being able to go fast without running extensive process development. So it takes a long time to develop the process today because of this diversific…
Article
High-Throughput Process Development in an Historical Environment
HTPD approaches in downstream goes beyond chromatography
The approaches in downstream process development, with screening of chromatography resins and parallel screening of optimal process conditi…
Article
Top Process Development Trends for 2022 and a Look into 2023
As we move into 2023, let’s look back at some of the most popular 2022 articles from the Bioprocess Development Forum.
More Hands-on Content, as the Industry Struggles to Keep Up with the Science …
Article
Process Development: What May Lie Ahead in 2018?
What have 2017 developments taught us, and what may lie ahead for biopharmaceutical drug developers and process engineers? Here, we look at some of the most popular Process Development Forum articles …
Article
Critical Quality Attributes Challenge Biologics Development
The complex nature of biologics adds additional CQAs that must be determined to ensure the safe development of biologics.
By Susan Haigney
Critical quality attributes (CQAs) are used in biop…
Article
Breakthrough Drugs Raise Development and Production Challenges
Achieving fast approval of a breakthrough therapy creates challenges for manufacturers looking to develop CMC data in roughly half the time, noted Brian Kelley, vice-president for bioprocess developme…
Article
Biosimilars Development and Supply: How Complex Can the Process Be?
As the complex requirements of manufacturing biologics are manifold, it is important that biomanufacturing companies adopt quality-by-design principles.
Countries around the world face a gro…